ACRES COMMERCIAL REALTY CORP (ACR) Stock Fundamental Analysis
NYSE:ACR - New York Stock Exchange, Inc. - US00489Q1022 - REIT - Currency: USD
We assign a fundamental rating of 3 out of 10 to ACR. ACR was compared to 65 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. There are concerns on the financial health of ACR while its profitability can be described as average. ACR has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year ACR was profitable.
ACR had a positive operating cash flow in the past year.
In multiple years ACR reported negative net income over the last 5 years.
Each year in the past 5 years ACR had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ACR (0.48%) is better than 61.54% of its industry peers.
With a Return On Equity value of 2.08%, ACR is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
ACR has a Return On Invested Capital of 0.54%. This is in the better half of the industry: ACR outperforms 63.08% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACR is in line with the industry average of 1.42%.
The 3 year average ROIC (0.54%) for ACR is below the current ROIC(0.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.48% | ||
| ROE | 2.08% | ||
| ROIC | 0.54% |
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.54%
ROIC(5y)N/A
1.3 Margins
ACR's Profit Margin of 4.57% is in line compared to the rest of the industry. ACR outperforms 43.08% of its industry peers.
In the last couple of years the Profit Margin of ACR has declined.
Looking at the Operating Margin, with a value of 5.81%, ACR is doing worse than 61.54% of the companies in the same industry.
ACR's Operating Margin has declined in the last couple of years.
ACR's Gross Margin of 38.58% is amongst the best of the industry. ACR outperforms 81.54% of its industry peers.
ACR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.81% | ||
| PM (TTM) | 4.57% | ||
| GM | 38.58% |
OM growth 3Y-45.63%
OM growth 5Y-26.08%
PM growth 3Y-34.18%
PM growth 5Y-23.69%
GM growth 3Y-1.09%
GM growth 5Y1.39%
2. Health
2.1 Basic Checks
ACR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ACR has less shares outstanding
ACR has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ACR has been reduced compared to a year ago.
2.2 Solvency
ACR has an Altman-Z score of -0.44. This is a bad value and indicates that ACR is not financially healthy and even has some risk of bankruptcy.
ACR has a Altman-Z score of -0.44. This is in the lower half of the industry: ACR underperforms 64.62% of its industry peers.
ACR has a Debt/Equity ratio of 2.80. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.80, ACR is in the better half of the industry, outperforming 72.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.8 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.44 |
ROIC/WACC0.08
WACC6.79%
2.3 Liquidity
A Current Ratio of 0.36 indicates that ACR may have some problems paying its short term obligations.
ACR's Current ratio of 0.36 is fine compared to the rest of the industry. ACR outperforms 61.54% of its industry peers.
ACR has a Quick Ratio of 0.36. This is a bad value and indicates that ACR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ACR (0.36) is better than 61.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.36 | ||
| Quick Ratio | 0.36 |
3. Growth
3.1 Past
The earnings per share for ACR have decreased strongly by -81.86% in the last year.
Measured over the past years, ACR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.41% on average per year.
ACR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.64%.
Measured over the past years, ACR shows a small growth in Revenue. The Revenue has been growing by 6.60% on average per year.
EPS 1Y (TTM)-81.86%
EPS 3Y-14.61%
EPS 5Y-15.41%
EPS Q2Q%-637.5%
Revenue 1Y (TTM)-13.64%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%-9.41%
3.2 Future
ACR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -11.83% yearly.
ACR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.44% yearly.
EPS Next Y-62.22%
EPS Next 2Y-11.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.91%
Revenue Next 2Y-9.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 48.05 indicates a quite expensive valuation of ACR.
64.62% of the companies in the same industry are cheaper than ACR, based on the Price/Earnings ratio.
ACR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.57.
With a Price/Forward Earnings ratio of 16.45, ACR is valued correctly.
Based on the Price/Forward Earnings ratio, ACR is valued a bit more expensive than 66.15% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ACR to the average of the S&P500 Index (22.41), we can say ACR is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.05 | ||
| Fwd PE | 16.45 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACR indicates a rather cheap valuation: ACR is cheaper than 81.54% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 67.47 |
4.3 Compensation for Growth
ACR's earnings are expected to decrease with -11.83% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.83%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ACR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:ACR (6/16/2025, 8:25:53 PM)
17.78
-0.23 (-1.28%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)
Earnings (Next)
Inst Owners42.26%
Inst Owner Change18.42%
Ins Owners3.48%
Ins Owner Change-0.12%
Market Cap131.39M
Analysts76.67
Price Target22.44 (26.21%)
Short Float %0.81%
Short Ratio1.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend2.58
Dividend Growth(5Y)-6.08%
DP219.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.88%
Min EPS beat(2)-39.59%
Max EPS beat(2)79.34%
EPS beat(4)2
Avg EPS beat(4)-4.01%
Min EPS beat(4)-65.56%
Max EPS beat(4)79.34%
EPS beat(8)6
Avg EPS beat(8)12.99%
EPS beat(12)9
Avg EPS beat(12)8.68%
EPS beat(16)10
Avg EPS beat(16)-15.79%
Revenue beat(2)1
Avg Revenue beat(2)0.8%
Min Revenue beat(2)-3.39%
Max Revenue beat(2)4.99%
Revenue beat(4)1
Avg Revenue beat(4)-3.54%
Min Revenue beat(4)-13.77%
Max Revenue beat(4)4.99%
Revenue beat(8)5
Avg Revenue beat(8)7.31%
Revenue beat(12)9
Avg Revenue beat(12)53.21%
Revenue beat(16)13
Avg Revenue beat(16)80.35%
PT rev (1m)0%
PT rev (3m)12.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)57.5%
EPS NY rev (1m)0%
EPS NY rev (3m)-72.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)8.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 48.05 | ||
| Fwd PE | 16.45 | ||
| P/S | 0.66 | ||
| P/FCF | N/A | ||
| P/OCF | 6.92 | ||
| P/B | 0.3 | ||
| P/tB | 0.3 | ||
| EV/EBITDA | 67.47 |
EPS(TTM)0.37
EY2.08%
EPS(NY)1.08
Fwd EY6.08%
FCF(TTM)-3.52
FCFYN/A
OCF(TTM)2.57
OCFY14.46%
SpS27.01
BVpS59.4
TBVpS58.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.48% | ||
| ROE | 2.08% | ||
| ROCE | 0.69% | ||
| ROIC | 0.54% | ||
| ROICexc | 0.56% | ||
| ROICexgc | 0.57% | ||
| OM | 5.81% | ||
| PM (TTM) | 4.57% | ||
| GM | 38.58% | ||
| FCFM | N/A |
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.54%
ROIC(5y)N/A
ROICexc(3y)0.56%
ROICexc(5y)N/A
ROICexgc(3y)0.56%
ROICexgc(5y)N/A
ROCE(3y)0.68%
ROCE(5y)N/A
ROICexcg growth 3Y-26.8%
ROICexcg growth 5Y-15.02%
ROICexc growth 3Y-26.89%
ROICexc growth 5Y-15.13%
OM growth 3Y-45.63%
OM growth 5Y-26.08%
PM growth 3Y-34.18%
PM growth 5Y-23.69%
GM growth 3Y-1.09%
GM growth 5Y1.39%
F-Score8
Asset Turnover0.11
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.8 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 57.73 | ||
| Cap/Depr | 464.4% | ||
| Cap/Sales | 22.55% | ||
| Interest Coverage | 0.1 | ||
| Cash Conversion | 89.24% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.36 | ||
| Quick Ratio | 0.36 | ||
| Altman-Z | -0.44 |
F-Score8
WACC6.79%
ROIC/WACC0.08
Cap/Depr(3y)765.92%
Cap/Depr(5y)459.64%
Cap/Sales(3y)30.68%
Cap/Sales(5y)18.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.86%
EPS 3Y-14.61%
EPS 5Y-15.41%
EPS Q2Q%-637.5%
EPS Next Y-62.22%
EPS Next 2Y-11.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.64%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%-9.41%
Revenue Next Year-3.91%
Revenue Next 2Y-9.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.89%
EBIT growth 3Y-34.19%
EBIT growth 5Y-21.2%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-425%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.7%
OCF growth 3Y-22.36%
OCF growth 5Y-15.19%